Skip to main content

Nasdaq IPOs

Oncology biotech Ayala Pharmaceuticals sets terms for $50 million IPO

6 years 4 months ago
Ayala Pharmaceuticals, a Phase 2 biotech developing small molecule therapies for aggressive cancers, announced terms for its IPO on Monday. The Rehovot, Israel-based company plans to raise $50 million by offering 3.3 million shares at a price range of $14 to $16. At the midpoint
Renaissance Capital

US IPO Week Ahead: GAN bets on itself in a 3 IPO week

6 years 4 months ago
Updated on 5/4/2020  Three IPOs and one SPAC are scheduled for the week ahead. Internet gambling software provider GAN Limited (GAN) plans to raise $48 million at a $224 million fully diluted market cap after upsizing its deal by 57%. The London-based company has been focusi
Renaissance Capital

US IPO Week Ahead: GAN bets on itself in a 1 IPO week

6 years 4 months ago
Just one IPO is scheduled for the week ahead, though there are a handful of deals in the IPO pipeline that are primed for May public offerings. Internet gambling software provider GAN Limited (GAN) plans to raise $48 million at a $224 million fully diluted market cap after upsizi
Renaissance Capital

Cannabis SPAC Collective Growth Corp prices $150 million IPO at $10

6 years 4 months ago
Collective Growth Corp, a blank check company led by former Canopy Growth execs targeting the cannabis industry, raised $150 million by offering 15 million units at $10. Each unit consists of one share of common stock and one half of a warrant exercisable at $11.50. At $10,
Renaissance Capital

ENT biotech Lyra Therapeutics prices IPO at $16 high end

6 years 4 months ago
Lyra Therapeutics, a Phase 2 biotech developing an implantable drug-device for chronic rhinosinusitis, raised $56 million by offering 3.5 million shares at $16, the high end of the range of $14 to $16. Lyra Therapeutics plans to list on the Nasdaq under the symbol LYRA. BofA Secu
Renaissance Capital

Fortive carve-out Vontier withdraws estimated $1 billion IPO

6 years 4 months ago
Vontier, the global industrial company focused on transportation and mobility carved out of Fortive, withdrew its plans for an initial public offering on Thursday after delaying in the 1Q20, citing recent market and economic disruptions caused by the COVID-19 pandemic. It origina
Renaissance Capital

How SPACs went mainstream

6 years 5 months ago
SPACs are making big moves. This past week, sports betting platform DraftKings (DKNG) entered the public market through a SPAC merger, and Chamath Palihapitiya’s Social Capital Hedosophia II (IPOBU) and III (IPOCU) raised a combined $1 billion. Blank check IPOs have hit rec
Renaissance Capital

How SPACs went mainstream

6 years 5 months ago
SPACs are making big moves. This past week, sports betting platform DraftKings (DKNG) entered the public market through a SPAC merger, and Chamath Palihapitiya’s Social Capital Hedosophia II (IPOBU) and III (IPOCU) raised a combined $1 billion. Blank check IPOs have hit rec
Renaissance Capital

Tech SPAC Novus Capital Corp files for a $100 million IPO

6 years 5 months ago
Novus Capital Corp, a blank check company targeting the smart technology innovations market, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering. The Indianapolis, IN-based company plans to raise $100 million by offering 10 million units at $10
Renaissance Capital
Checked
7 minutes 5 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed